Roderick C.N. van den Bergh

Roderick C.N. van den Bergh is a Researcher at the Department of Urology, Erasmus University Medical Center. His work focuses on prostate cancer, diagnostic imaging techniques (e.g., MRI, PSMA-PET/CT), and clinical management strategies. He collaborates internationally on multicenter studies involving institutions across Europe.

Key research interests include optimizing prostate cancer screening via MRI capacity assessment, evaluating adjuvant therapies for node-positive prostate cancer, and refining risk stratification models to reduce overtreatment. His contributions span over 111 publications, emphasizing evidence-based approaches in urology and oncology.

Recent studies highlight his involvement in the European Randomized Study of Screening for Prostate Cancer (ERSPC) Rotterdam group and collaborations with the Young Academic Urologists Prostate Cancer Working Group. His work bridges diagnostic innovation (e.g., PSMA-PET/CT staging) with clinical outcomes, particularly in surgical and radiation therapy contexts.

Dr. van den Bergh’s research underscores the importance of imaging advancements in guiding personalized treatment plans and improving patient outcomes in uro-oncological care.